Delivery Order SPE2DB22D2006-SPE2DB25FV7XM

Award Date 1/28/25
Potential Completion Date 1/29/25
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with an ID of SPE2DB22D1202|SPE2DB25FUMT8, was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of PRIORIX VIALS and has a ceiling value of $10,687.08. It is a Delivery Order contract with a Firm Fixed Price pricing type and an ultimate completion date of December 17, 2024. The contract was awarded on December 16, 2024, and there was no set-aside designation used. Amerisourcebergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,664.85, is for the delivery of PRIORIX VIALS, a medical product. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is January 23, 2025. The award is associated with a larger Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,395.00 firm fixed-price delivery order contract is for the supply of PRIORIX VIALS, a medical product. The contract has an ultimate completion date of October 23, 2024 and was awarded on October 22, 2024. This appears to be a task order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
This federal contract award, valued at $18,540.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PRIORIX VIALS, a medical product, with a completion date of October 29, 2024. This is a Firm Fixed Price Delivery Order contract, which is not designated as a set-aside. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of PRIORIX VIALS (Contract ID: SPE2DB22D2009|SPE2DB24FL8XX). The contract has a total ceiling value of $49,755.80 and is a firm fixed price delivery order with an ultimate completion date of April 1, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which is not associated with any set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $49,715.40 firm-fixed-price delivery order is for the supply of PRIORIX VIALS, a medical product, with a period of performance through September 4, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
This federal contract award is for the supply of PRIORIX VIALS to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation. The contract has a ceiling value of $48,790.00 and is structured as a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of PRIORIX Vials, a pharmaceutical product. The award has a ceiling value of $15,426.43 and a completion date of August 8, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this order, which is part of a larger Indefinite Delivery Contract (IDC) valued up...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract, valued at $4,058.40, is for the delivery of PRIORIX VIALS, a pharmaceutical product. This is a Firm Fixed Price Delivery Order contract, with an ultimate completion date of August 28, 2024. The contract has no set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
This federal contract award is a delivery order valued at $17,135.66 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of PRIORIX VIALS, a pharmaceutical product, with a completion date of November 27, 2024. The contract is a firm fixed-price agreement with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB25FV7XM
    Delivery Order

This federal contract award, with the ID SPE2DB22D2006|SPE2DB25FV7XM, was granted by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of PRIORIX VIALS, a medical product, with a ceiling value of $11,549.92 and a completion date of January 29, 2025.

The contract is a Delivery Order with a Firm Fixed Price pricing type. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the DLA Troop Support Medical. The company maintains a significant Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/4/25, 12:53 AM